BionovoH continues to promote innovation of R&D and product process
BionovoH continues to promote innovation of R&D and production process, and has established an integrated product development system covering product design, formulation development, drug delivery, function optimization, process verification, quality research and control, animal test evaluation, in vivo metabolism tracking, and clinical verification. The company is being led by innovation and quality.
-
Material compounding technologyThrough specific technology, organic polymers and biomacromolecule materials are selectively compounded to give play to the comprehensive advantages of material biocompatibility, mechanical properties, and material functionalization, and further regulate the degradation time in the body. -
Unique physical crosslinking technologyWith innovative preparation process, intermolecular hydrogen bonds are broken and rearranged to achieve the purpose of physical crosslinking and avoid the toxic and side effects of chemical crosslinking agent residues in the body.
-
Self-assembly technologyBy the use of the electrostatic interactions, hydrophilic and hydrophobic interactions, as well as the formation of hydrogen and disulfide bonds between material molecules, we induce self-assembly of materials and develop new properties and innovative formulations of materials.
-
Additive manufacturing technologyThrough 3D printing and electrospinning technology, three- and two-dimensional tissue engineeried scaffold materials are prepared, so that the materials can promote in-situ regeneration and repair after being implanted in the body.
-
Local targeted drug delivery systemThrough formulation innovation, local targeting and slow-release and controlled-release drug delivery are achieved, so as to avoid the toxicity and side effects caused by systemic drug delivery and improve the drug compliance.
-
Gene editing technologyGene editing technology is applied to develop new humanized materials for tissue repair.